Your session is about to expire
← Back to Search
Vibrogent Smartphone Application for Mucositis
N/A
Waitlist Available
Led By Harry Quon, M.D.
Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
Study Summary
This trial is testing whether a mobile app can help manage pain from radiation sores (mucositis) for people with head and neck cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline in "out of clinic" pain at 2 months
Secondary outcome measures
Change from baseline mucositis pain at 2 months
Trial Design
1Treatment groups
Experimental Treatment
Group I: Vibrent Smartphone ApplicationExperimental Treatment1 Intervention
We propose to pilot the application of the mobile application "VibrentTM" (research procedure) during a course of head and neck radiotherapy for eligible study subjects. Study subjects will be prospective consented and enrolled and will have baseline "out of clinic" assessment with the Vibrent smartphone application (research procedure).
Find a Location
Who is running the clinical trial?
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
558 Previous Clinical Trials
32,872 Total Patients Enrolled
1 Trials studying Mucositis
Harry Quon, M.D.Principal InvestigatorThe SKCCC at Johns Hopkins
2 Previous Clinical Trials
20 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger